Are researchers able to access trial data? Audit provides insights on data sharing from industry-sponsored studies
A recent study published in BMC Medicine audits data sharing from pharmaceutical industry-sponsored clinical studies.
The elimination of negative study results: reporting and citation bias
Is the apparent efficacy of treatments being altered by bias? A recent study takes a closer look at the cumulative effects of reporting and citation biases.
Google launches Dataset Search
Google launches a new search tool to facilitate the discoverability of public datasets.
New EU trials tracker reveals that half of European clinical trials have broken reporting rules
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
Meeting report: summary of the 14th Annual Meeting of ISMPP – Part 2
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
Clinical trial transparency: are non-commercial funders lagging behind industry sponsors?
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.
A new series from The BMJ highlights unreported trials
A new, regular series in The BMJ will highlight a different unreported clinical trial every week, with the intention of improving reporting rates.
What proportion of clinical trial data is reported? TrialsTracker launches new monitoring tool
The FDAAA 2007 requires clinical trials to make results publicly available 12 months after study completion. A new tool from TrialsTracker provides a live online report on compliance.
Meeting report: summary of day 1 of the 2018 Annual TIPPA Meeting
Missed TIPPA 2018? Read our meeting report to get up to speed!
[VIDEO] ISMPP European Meeting 2018: conference summary (day 2)
Missed ISMPP EU 2018? Duncan Campbell provides a summary of day 2 of the meeting.
Meeting report: summary of day 1 of the 2018 European ISMPP Meeting
Missed ISMPP EU 2018? Read our meeting report to get up to speed!
Three steps to transparency in clinical research: a new white paper from the Collaboration for Research Integrity and Transparency
Integrity and transparency are paramount to the accuracy, accessibility and credibility of medical research. Given that clinical evidence informs market approval of medical products, missing or inaccurate clinical trial data … Continue Reading Three steps to transparency in clinical research: a new white paper from the Collaboration for Research Integrity and Transparency
The evolution of regulations for improved clinical trial transparency
The ongoing push towards increased transparency around clinical trials has seen the evolution of regulatory requirements for data reporting and sharing in Europe and the US over the past decade. … Continue Reading The evolution of regulations for improved clinical trial transparency
Meeting report: Summary of Day 1 of the 2017 European #ISMPP Meeting
Over two days last week (17-18 January, 2017), around 250 delegates and exhibitors attended the 2017 European meeting of the International Society for Medical Publication Professionals (ISMPP) in London. The … Continue Reading Meeting report: Summary of Day 1 of the 2017 European #ISMPP Meeting
Company-sponsored clinical transparency rates continue to improve
Despite regulatory requirements and industry commitments, analyses of clinical trial transparency rates continue to report that not all clinical trial results are published within the required timelines, or at all. … Continue Reading Company-sponsored clinical transparency rates continue to improve
TrialsTracker attempts to identify trials with potentially unreported results
It has been suggested that a sizeable number of registered clinical trials fail to report their results, and that negative or null results are especially likely to remain unpublished. To help tackle … Continue Reading TrialsTracker attempts to identify trials with potentially unreported results